EBITDA Summary of Raffles Medical Group Ltd

Raffles Medical Group Ltd's latest annual EBITDA in 2023 was 132.88 Million SGD , down -48.32% from previous year.
Raffles Medical Group Ltd's latest quarterly EBITDA in 2024 Q2 was 30 Million SGD , down 0.0% from previous quarter.
Raffles Medical Group Ltd reported an annual EBITDA of 235.87 Million SGD in 2022, up 57.97% from previous year.
Raffles Medical Group Ltd reported an annual EBITDA of 161.26 Million SGD in 2021, up 28.16% from previous year.
Raffles Medical Group Ltd reported a quarterly EBITDA of 30 Million SGD for 2024 Q2, down 0.0% from previous quarter.
Raffles Medical Group Ltd reported a quarterly EBITDA of 19.16 Million SGD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Raffles Medical Group Ltd (2023 - 2001)

Historical Annual EBITDA of Raffles Medical Group Ltd (2023 - 2001)

Year	EBITDA	EBITDA Growth
2023	132.88 Million SGD	-48.32%
2022	235.87 Million SGD	57.97%
2021	161.26 Million SGD	28.16%
2020	125.08 Million SGD	16.29%
2019	107.12 Million SGD	5.42%
2018	103.59 Million SGD	7.89%
2017	96.01 Million SGD	-1.77%
2016	97.74 Million SGD	3.43%
2015	94.5 Million SGD	3.87%
2014	90.98 Million SGD	-12.14%
2013	103.55 Million SGD	38.59%
2012	74.72 Million SGD	11.64%
2011	66.93 Million SGD	10.96%
2010	60.32 Million SGD	15.12%
2009	52.4 Million SGD	14.8%
2008	45.64 Million SGD	40.72%
2007	32.48 Million SGD	56.18%
2006	22.63 Million SGD	32.56%
2005	15.66 Million SGD	12.32%
2004	13.94 Million SGD	8.04%
2003	12.91 Million SGD	38.0%
2002	9.35 Million SGD	239.69%
2001	2.75 Million SGD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	30 Million SGD	56.59%
2024 Q2	30 Million SGD	0.0%
2023 Q4	19.16 Million SGD	0.0%
2023 FY	- SGD	-46.8%
2023 Q3	19.16 Million SGD	-59.93%
2023 Q2	47.81 Million SGD	0.0%
2023 Q1	47.81 Million SGD	-28.03%
2022 Q2	101.22 Million SGD	89.48%
2022 FY	- SGD	57.97%
2022 Q3	66.43 Million SGD	-34.37%
2022 Q1	53.42 Million SGD	-34.17%
2022 Q4	66.43 Million SGD	0.0%
2021 Q4	81.14 Million SGD	136.05%
2021 FY	- SGD	28.16%
2021 Q1	37.27 Million SGD	-43.35%
2021 Q2	67.87 Million SGD	82.1%
2021 Q3	34.37 Million SGD	-49.35%
2020 Q4	65.79 Million SGD	151.3%
2020 FY	- SGD	16.29%
2020 Q2	41.75 Million SGD	99.46%
2020 Q3	26.18 Million SGD	-37.29%
2020 Q1	20.93 Million SGD	-36.43%
2019 Q4	32.92 Million SGD	31.24%
2019 FY	- SGD	5.42%
2019 Q1	24.78 Million SGD	-19.47%
2019 Q3	25.09 Million SGD	-4.98%
2019 Q2	26.4 Million SGD	6.54%
2018 Q4	30.77 Million SGD	27.33%
2018 FY	- SGD	7.89%
2018 Q3	24.17 Million SGD	-4.15%
2018 Q2	25.21 Million SGD	7.66%
2018 Q1	23.42 Million SGD	-16.99%
2017 Q4	28.21 Million SGD	26.62%
2017 Q3	22.28 Million SGD	-5.25%
2017 Q2	23.52 Million SGD	6.95%
2017 Q1	21.99 Million SGD	-23.02%
2017 FY	- SGD	-1.77%
2016 Q1	22.59 Million SGD	-22.16%
2016 FY	- SGD	3.43%
2016 Q4	28.57 Million SGD	26.13%
2016 Q2	23.92 Million SGD	5.89%
2016 Q3	22.65 Million SGD	-5.34%
2015 Q2	22.52 Million SGD	7.83%
2015 FY	- SGD	3.87%
2015 Q4	29.03 Million SGD	31.63%
2015 Q3	22.05 Million SGD	-2.09%
2015 Q1	20.89 Million SGD	-28.69%
2014 FY	- SGD	-12.14%
2014 Q2	21.13 Million SGD	7.91%
2014 Q3	20.96 Million SGD	-0.81%
2014 Q1	19.58 Million SGD	-57.57%
2014 Q4	29.29 Million SGD	39.75%
2013 Q2	19.82 Million SGD	7.38%
2013 FY	- SGD	38.59%
2013 Q1	18.45 Million SGD	-34.4%
2013 Q4	46.16 Million SGD	142.18%
2013 Q3	19.06 Million SGD	-3.83%
2012 FY	- SGD	11.64%
2012 Q1	16.17 Million SGD	-30.67%
2012 Q3	17.18 Million SGD	1.0%
2012 Q4	28.13 Million SGD	63.79%
2012 Q2	17.01 Million SGD	5.18%
2011 Q1	14.83 Million SGD	-30.08%
2011 Q3	16.28 Million SGD	-0.32%
2011 FY	- SGD	10.96%
2011 Q4	23.32 Million SGD	43.26%
2011 Q2	16.33 Million SGD	10.14%
2010 Q1	12.9 Million SGD	-11.71%
2010 Q4	21.21 Million SGD	42.56%
2010 FY	- SGD	15.12%
2010 Q3	14.88 Million SGD	1.22%
2010 Q2	14.7 Million SGD	13.94%
2009 FY	- SGD	14.8%
2009 Q3	13.63 Million SGD	7.46%
2009 Q2	12.68 Million SGD	11.1%
2009 Q1	11.42 Million SGD	0.0%
2009 Q4	14.61 Million SGD	7.19%
2008 FY	- SGD	40.72%
2007 FY	- SGD	56.18%
2006 FY	- SGD	32.56%
2005 FY	- SGD	12.32%
2004 FY	- SGD	8.04%
2003 FY	- SGD	38.0%
2002 FY	- SGD	239.69%
2002 Q4	6.17 Million SGD	0.0%
2002 Q2	3.8 Million SGD	0.0%
2001 FY	- SGD	0.0%

Peer EBITDA Comparison of Raffles Medical Group Ltd

Name	EBITDA	EBITDA Difference
Q & M Dental Group (Singapore) Limited	39.69 Million SGD	-234.752%

Global Stocks Search

Raffles Medical Group Ltd (BSL.SI)

EBITDA Summary of Raffles Medical Group Ltd

Annual EBITDA Chart of Raffles Medical Group Ltd (2023 - 2001)

Historical Annual EBITDA of Raffles Medical Group Ltd (2023 - 2001)

Peer EBITDA Comparison of Raffles Medical Group Ltd